Zibotentan (ZD4054)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Zibotentan (ZD4054), covering 2010-11-15 to 2014-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer [Phase 2]